The new device features a compact design and a Smart-Dose compliant dose saving system that can reduce the amount of radiation for the patient undergoing imaging, the company said.
“Supria demonstrates Hitachi’s continuing commitment to provide superior product value by combining the latest imaging technologies in a design that while compact, still affords the premium patient accommodation features of more expensive systems including a 75cm gantry aperture, standard 1.8 meter scannable range table with 500 lb. weight capacity,” CT marketing director Mark Silverman said in a press release.
The company said that while the dose saving feature can reduce the CT patient dose, a radiologist and physicist should be consulted with to determine the appropriate dose depending on the clinical task, patient size and anatomical location of the scan.
“The Supria provides a strong value-based solution for CT providers needing to replace older higher-dose ≤16-slice CT Systems with a new lower-dose Smart Dose compliant (XR-29) system. The dose reduction features included standard with Supria actually surpass the XR-29 Standard,” MR/CT veep Sheldon Schaffer said in prepared remarks.
Last week, Neurological device maker NICO and Hitachi said they are collaborating to create an ultrasound probe to aid in brain tumor operations using Nico’s BrainPath device.
Hitachi’s Aloka ultrasound probe, which is still being developed, will be usable with Nico’s BrainPath device to allow operators better visualization of the location, size, and proximity of vessels during resection operations, the company said.